Last mentioned: Mar 2, 2026
FY28 Strategic Goal
Smith & Nephew targets 22% trading profit margin milestone.
FY26 Targets
SNN aims for 20%+ trading profit margin; AAON targets double-digit growth.
FY25 Guidance
SNN targets 18.5%-19.5% margin; AAON expects mid-single digit growth.
FY24 Close
SNN reports $5.83B revenue; AAON reports $306.6M Q4 revenue.
Smith & Nephew and AAON both reported Q4 results that emphasize long-term margin expansion and revenue targets through 2026 and beyond. While AAON faced a mixed quarter with flat revenue growth, Smith & Nephew's multi-year guidance suggests a structural turnaround in its orthopaedics and wound care segments.
Smith & Nephew (SNN) has reported its fourth-quarter results and provided a multi-year financial outlook through 2028, signaling a pivot toward sustained growth. The company is leveraging strategic partnerships, including a collaboration with SI-BONE, to expand its footprint in high-growth medtech segments.
Smith & Nephew has introduced ambitious financial targets for FY26 and FY28, signaling a definitive shift from its operational recovery phase to a sustained growth trajectory. The company’s Q4 results underscore the resilience of its Orthopaedics and Sports Medicine segments, supported by the continued rollout of the CORI robotics platform.